18:0 DAP
18:0 DAP can be used to formulate lipid nanoparticles (LNPs), which mRNA is encapsulated in their core[1].
Product Specifications
CAS Number
[121315-93-3]
UNSPSC
12352200
Hazard Statement
H302, H315, H319, H331, H336, H351, H361, H372
Target
Liposome
Type
Biochemical Assay Reagents
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/18-0-dap.html
Purity
99.99
Solubility
10 mM in DMSO
Smiles
CN(CC(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O)C
Molecular Formula
C41H81NO4
Molecular Weight
652.09
Precautions
H302, H315, H319, H331, H336, H351, H361, H372
References & Citations
[1]Patel S, et al. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019;303:91-100.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1386061-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O157:H7 Laminin-binding fimbrial subunit ElfA (elfA)
Ask
View Details MBS1386061-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O157:H7 Laminin-binding fimbrial subunit ElfA (elfA)
Ask
View Details 
MBS1386061-03 0.02 mg (Yeast)
Recombinant Escherichia coli O157:H7 Laminin-binding fimbrial subunit ElfA (elfA)
Ask
View Details 
MBS1386061-04 0.1 mg (Yeast)
Recombinant Escherichia coli O157:H7 Laminin-binding fimbrial subunit ElfA (elfA)
Ask
View Details MBS1386061-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O157:H7 Laminin-binding fimbrial subunit ElfA (elfA)
Ask
View Details